Trial intelligence / Profile preview

Biodentine vs MTA Pulpotomies in Primary Molars

NCT03395496Phase 1Completed

Sponsor
Istanbul University
Start
May 2013
Primary completion
May 2016
Countries
1
01

Overview

Phase 1, randomised trial (2 arms), sponsored by Istanbul University. Primary endpoint: Total success rate at 12 months. Started May 2013; status: completed.

Beyond the preview

Go deeper on NCT03395496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03395496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call